Skip to content
‹ Back to IndustriesHealthcare

THE INS AND OUTS OF TRANSDERMAL DRUG DELIVERY SYSTEMS

When designing new drug therapies, pharmaceutical and medical device companies must determine which method is best for delivering the medication to the target sites. Patients are generally familiar with drugs delivered via oral, topical, intravenous, and intramuscular routes. Transdermal drug delivery is the application of a medicine or drug through the skin, typically by using…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

When designing new drug therapies, pharmaceutical and medical device companies must determine which method is best for delivering the medication to the target sites. Patients are generally familiar with drugs delivered via oral, topical, intravenous, and intramuscular routes. Transdermal drug delivery is the application of a medicine or drug through the skin, typically by using an adhesive patch, so that it is absorbed slowly into the body. It is becoming an increasingly popular option as it allows for a controlled release of medication while its ease-of-use enhances patient adherence.

The ABC’s of TDDS 

A Transdermal Drug Delivery System (TDDS) administers medication through intact human skin at a controlled rate to the systemic circulation. Oftentimes a patch or adhesive is used where the dosage either passes through a porous membrane containing the drug, or body heat melts layers of medication integrated within the adhesive. While oral medications can sometimes prove problematic to the digestive tract and liver, transdermal drugs bypass the digestive system and enter the bloodstream at a controlled rate regulated by the skin. As a result, patients using a TDDS may experience improved dosage efficacy compared to other delivery systems.

Advantages and Disadvantages 

Delivery of medication through an oral route isn’t always an available option as the medication may not be properly absorbed due to gastrointestinal acid, enzymatic activity, or interference with food, drink, or other types of oral drugs. Transdermal administration can prove to be a superior alternative in this instance as it avoids first-pass metabolism and drug deactivation by liver enzymes. It is also ideal for drugs that have a narrow therapeutic window. The method is non-invasive and provides extended therapy with a single application. A TDDS patch can be quickly terminated by removing the patch from the skin. Also, because physical patches are visible, emergency responders and clinicians can quickly identify the drug that an unresponsive, unconscious or comatose patient is using.

Transdermal drugs do have some disadvantages. Since the skin provides a barrier it can limit potent drug molecules, prohibiting delivery into the blood. Patches may cause some skin irritation in certain patients, while others may object to their comfort and cosmetic levels, possibly decreasing compliance.

Enhancing TDDS with Electronics

Skin tolerability, skin barrier properties, and variability of application site conditions can all be constraints limiting the viability of drug delivery via a transdermal route. With the help of electronics, effective drug delivery via TDDS is possible. Iontophoresis is a technique of introducing ionic medicinal compounds into the body through the skin by applying a local electric current. Another approach to enhancing TDDS is microporation of the biological barrier, which involves applying an alternating current to microelectrodes and making contact with the skin. Additionally, skin microporation can also be achieved by using very short laser pulses.

Click here to read more about Nick Lesniewski-Laas

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Denials get a queue, underpayments just look like paid claims

Denials get a queue, underpayments just look like paid claims

Underpayments in healthcare revenue cycle operations lack the visibility of denied claims because they don't trigger alerts or queue workflows. Without dedicated ownership and line-level verification against contract terms, paid claims that fall short of their contractual amount pass through undetected.

  • 01Denial workflows activate on rejection events, but underpayments produce no event, leaving paid claims unverified by default.
  • 02The speaker says many provider groups lack line-level contract intelligence to check each paid line against the applicable terms.
  • 03Payment received and payment checked are separate tasks: one verifies acceptance, the other verifies correctness—and the second often has no assigned owner.

Nov 6, 2026

A zero-paid claim line is not automatically an underpayment

A zero-paid claim line is not automatically an underpayment

A zero payment on a claim line isn't automatically an underpayment; contract terms, particularly packaging rules, determine whether zero is correct. Chasing unsupported findings damages credibility with payers and weakens the position of legitimate disputes, so revenue cycle teams must verify the full contract terms and effective dates before treating any payment difference as a finding.

  • 01When a contract packages add-ons into the primary procedure, the add-on line may legitimately show zero payment because it is folded into the primary procedure reimbursement.
  • 02Pursuing payment differences that lack contract support burns credibility with payers and can weaken the team’s position on later disputes, including valid ones.
  • 03Always verify the complete contract terms, fee schedules, carve-outs, amendments, and the specific version in effect on the date of service before treating a payment variance as a recoverable underpayment.

Nov 6, 2026

A clean, paid, closed claim can still be short of the contract

A clean, paid, closed claim can still be short of the contract

Practices can receive payment on closed, clean claims that still fall short of negotiated contract amounts because billing ends at coding, submission and posting, while no role owns checking whether payer payments match fee schedules. The speaker argues that contract-level payment review is a separate, complementary function that compares closed claims to contract terms and, run continuously, helps surface shortfalls in time to act within timely filing windows.

  • 01Correctly coded and billed healthcare claims can still result in underpayment.
  • 02Check closed-claim payments against contract terms to find underpayments.
  • 03Discrepancies in claim payments can persist despite adherence to billing protocols.

Nov 6, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512